首页> 外文OA文献 >Autologous vs. allogenic mesenchymal progenitor cells for the reconstruction of critical-sized segmental tibial bone defects in aged sheep
【2h】

Autologous vs. allogenic mesenchymal progenitor cells for the reconstruction of critical-sized segmental tibial bone defects in aged sheep

机译:自体vs.同种异体间充质祖细胞重建老龄绵羊临界大小的胫骨节段骨缺损

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mesenchymal progenitor cells (MPCs) represent an attractive cell population for bone tissue engineering. Their special immunological characteristics suggest that MPCs may be used in an allogenic application. The objective of this study was to compare the regenerative potential of autologous vs. allogenic MPCs in an ovine critical-sized segmental defect model. Ovine MPCs were isolated from bone marrow aspirates, expanded and cultured with osteogenic media for two weeks before implantation. Autologous and allogenic transplantation was performed by using the cell-seeded scaffolds, unloaded scaffolds and the application of autologous bone grafts served as control groups (n=6). Bone healing was assessed twelve weeks after surgery by radiology, micro computed tomography, biomechanical testing and histology. Radiology, biomechanical testing and histology revealed no significant difference in bone formation between the autologous and allogenic group. Both cell groups showed more bone formation than the scaffold alone, whereas the biomechanical data showed no significant differences between the cell-groups and the unloaded scaffolds. The results of the study suggest that scaffold based bone tissue engineering using allogenic cells offers the potential for an off the shelf product. Therefore, the results of this study serve as an important baseline for the translation of the assessed concepts into clinical application.
机译:间充质祖细胞(MPC)代表骨组织工程的有吸引力的细胞群。它们的特殊免疫学特征表明,MPC可用于同种异体应用。这项研究的目的是在绵羊临界大小的节段性缺损模型中比较自体和同种MPC的再生潜力。从植入物中分离出绵羊MPC,扩增,并在植入前用成骨培养基培养两周。通过使用细胞接种的支架,空载的支架进行自体和同种异体移植,并以自体骨移植物作为对照组(n = 6)。术后十二周通过放射学,显微计算机断层扫描,生物力学测试和组织学评估骨愈合情况。放射学,生物力学测试和组织学检查显示,自体和同种异体组之间的骨形成没有显着差异。两个细胞组均显示出比单独的支架更多的骨形成,而生物力学数据表明,细胞组与未加载的支架之间没有显着差异。研究结果表明,使用异体细胞的基于支架的骨组织工程提供了现成产品的潜力。因此,这项研究的结果作为将评估概念转化为临床应用的重要基线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号